nodes	percent_of_prediction	percent_of_DWPC	metapath
Aspartame—L-Phenylalanine—Melphalan—breast cancer	0.664	1	CrCrCtD
Aspartame—SLC22A11—Methotrexate—breast cancer	0.0347	0.503	CbGbCtD
Aspartame—SLC22A8—Methotrexate—breast cancer	0.0202	0.293	CbGbCtD
Aspartame—SLC22A6—Methotrexate—breast cancer	0.014	0.204	CbGbCtD
Aspartame—Lacosamide—SCN10A—breast cancer	0.00156	0.126	CrCbGaD
Aspartame—Lacosamide—CA9—breast cancer	0.00143	0.115	CrCbGaD
Aspartame—Ramipril—BCHE—breast cancer	0.00143	0.115	CrCbGaD
Aspartame—Bortezomib—PTGS1—breast cancer	0.00116	0.093	CrCbGaD
Aspartame—Bortezomib—CYP1A1—breast cancer	0.00106	0.0851	CrCbGaD
Aspartame—Bortezomib—CYP2D6—breast cancer	0.000789	0.0633	CrCbGaD
Aspartame—Bortezomib—CYP3A4—breast cancer	0.000676	0.0543	CrCbGaD
Aspartame—TAS1R2—Signaling by GPCR—PTHLH—breast cancer	0.000658	0.00259	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDH5—breast cancer	0.000649	0.00255	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.00064	0.00251	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EDNRB—breast cancer	0.000637	0.0025	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SFRP2—breast cancer	0.000636	0.0025	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000626	0.00246	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRLR—breast cancer	0.000625	0.00245	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000622	0.00244	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VCP—breast cancer	0.000603	0.00237	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GLI2—breast cancer	0.000603	0.00237	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000603	0.00237	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000603	0.00237	CbGpPWpGaD
Aspartame—Nateglinide—PTGS1—breast cancer	0.000595	0.0478	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—LEPR—breast cancer	0.000593	0.00233	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CALCA—breast cancer	0.000579	0.00228	CbGpPWpGaD
Aspartame—Lisinopril—ABCB1—breast cancer	0.000577	0.0463	CrCbGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCL12—breast cancer	0.000566	0.00222	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCR4—breast cancer	0.000566	0.00222	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ARHGDIA—breast cancer	0.000552	0.00217	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00055	0.00216	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000546	0.00215	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—COX11—breast cancer	0.000546	0.00215	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FST—breast cancer	0.000538	0.00211	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000532	0.00209	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HEY2—breast cancer	0.000531	0.00209	CbGpPWpGaD
Aspartame—TRPV1—Ion channel transport—RAF1—breast cancer	0.000529	0.00208	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RPS6KB2—breast cancer	0.000525	0.00206	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000521	0.00205	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000519	0.00204	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RGS2—breast cancer	0.000519	0.00204	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL20—breast cancer	0.000513	0.00202	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AGTR1—breast cancer	0.000512	0.00201	CbGpPWpGaD
Aspartame—Enalapril—CYP3A4—breast cancer	0.000509	0.0408	CrCbGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000503	0.00198	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000503	0.00198	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.0005	0.00196	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LPAR1—breast cancer	0.000497	0.00195	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TLE3—breast cancer	0.000497	0.00195	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HEY1—breast cancer	0.000492	0.00193	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.00049	0.00193	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DLL1—breast cancer	0.000482	0.0019	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000481	0.00189	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000481	0.00189	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HIST1H2BK—breast cancer	0.000473	0.00186	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HIST1H2BC—breast cancer	0.000473	0.00186	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GRB7—breast cancer	0.000469	0.00184	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDE4D—breast cancer	0.000469	0.00184	CbGpPWpGaD
Aspartame—Dextroamphetamine—CYP2D6—breast cancer	0.000467	0.0375	CrCbGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000465	0.00183	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TAB2—breast cancer	0.000461	0.00181	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ITPR1—breast cancer	0.000459	0.0018	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000459	0.0018	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CNR2—breast cancer	0.000457	0.0018	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CXCL8—breast cancer	0.000457	0.0018	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MMP3—breast cancer	0.000456	0.00179	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000447	0.00176	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DKK1—breast cancer	0.000446	0.00175	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VEGFC—breast cancer	0.000443	0.00174	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JAG2—breast cancer	0.000436	0.00171	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—WNT1—breast cancer	0.00043	0.00169	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PLA2G4A—breast cancer	0.000429	0.00169	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000427	0.00168	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CSF2—breast cancer	0.000424	0.00167	CbGpPWpGaD
Aspartame—Enalapril—ABCB1—breast cancer	0.000423	0.034	CrCbGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.00042	0.00165	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.00042	0.00165	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—COX11—breast cancer	0.000417	0.00164	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000417	0.00164	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000414	0.00163	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000412	0.00162	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH4—breast cancer	0.000407	0.0016	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GZMB—breast cancer	0.000405	0.00159	CbGpPWpGaD
Aspartame—Nateglinide—CYP2D6—breast cancer	0.000405	0.0325	CrCbGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000393	0.00155	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL2—breast cancer	0.000393	0.00154	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGTR2—breast cancer	0.000393	0.00154	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTHLH—breast cancer	0.000389	0.00153	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BMP2—breast cancer	0.000389	0.00153	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000381	0.0015	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.00038	0.00149	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000379	0.00149	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000377	0.00148	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDNRB—breast cancer	0.000376	0.00148	CbGpPWpGaD
Aspartame—Amphetamine—CYP2D6—breast cancer	0.000376	0.0302	CrCbGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000374	0.00147	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PGR—breast cancer	0.000373	0.00146	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—THBS1—breast cancer	0.000371	0.00146	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—PLG—breast cancer	0.000367	0.00144	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000367	0.00144	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000367	0.00144	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FLT1—breast cancer	0.000354	0.00139	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SQSTM1—breast cancer	0.000352	0.00138	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF3—breast cancer	0.000352	0.00138	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000352	0.00138	CbGpPWpGaD
Aspartame—Methamphetamine—CYP2D6—breast cancer	0.000349	0.028	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—JAG1—breast cancer	0.000348	0.00137	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—COX11—breast cancer	0.000348	0.00137	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000348	0.00137	CbGpPWpGaD
Aspartame—Nateglinide—CYP3A4—breast cancer	0.000347	0.0279	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—PARP1—breast cancer	0.000346	0.00136	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH3—breast cancer	0.000346	0.00136	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CALCA—breast cancer	0.000342	0.00134	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000339	0.00133	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RPS6—breast cancer	0.000338	0.00133	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF4—breast cancer	0.000336	0.00132	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCR4—breast cancer	0.000334	0.00131	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL12—breast cancer	0.000334	0.00131	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PAK1—breast cancer	0.000328	0.00129	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000325	0.00128	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TCF7L2—breast cancer	0.000322	0.00127	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CG—breast cancer	0.000318	0.00125	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000318	0.00125	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000316	0.00124	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000312	0.00123	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HSP90AA1—breast cancer	0.000311	0.00122	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH2—breast cancer	0.000311	0.00122	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000306	0.0012	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000306	0.0012	CbGpPWpGaD
Aspartame—Nateglinide—ALB—breast cancer	0.000303	0.0243	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—PRL—breast cancer	0.000302	0.00119	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGTR1—breast cancer	0.000302	0.00119	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.0003	0.00118	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000299	0.00118	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STK11—breast cancer	0.000298	0.00117	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADAM10—breast cancer	0.000298	0.00117	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PLG—breast cancer	0.000295	0.00116	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT2—breast cancer	0.000291	0.00114	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF10—breast cancer	0.00029	0.00114	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.00029	0.00114	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000289	0.00114	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CD—breast cancer	0.00028	0.0011	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFA—breast cancer	0.00028	0.0011	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFBR2—breast cancer	0.000276	0.00108	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ITPR1—breast cancer	0.000271	0.00107	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP3—breast cancer	0.000269	0.00106	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ERBB4—breast cancer	0.000269	0.00106	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STAT5A—breast cancer	0.000269	0.00106	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000269	0.00106	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000264	0.00104	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SMAD4—breast cancer	0.000261	0.00103	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IGF1R—breast cancer	0.000259	0.00102	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HES1—breast cancer	0.000255	0.001	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PLA2G4A—breast cancer	0.000253	0.000996	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NCOR1—breast cancer	0.000253	0.000996	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CSF2—breast cancer	0.00025	0.000984	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF1—breast cancer	0.00025	0.000984	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.00025	0.000984	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—RAF1—breast cancer	0.00025	0.000982	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000249	0.000979	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NRG1—breast cancer	0.000249	0.000977	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—H2AFX—breast cancer	0.000247	0.00097	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—E2F1—breast cancer	0.000245	0.000963	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000244	0.000959	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CB—breast cancer	0.000244	0.000959	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000242	0.00095	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000241	0.000948	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SPP1—breast cancer	0.000235	0.000926	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCL8—breast cancer	0.000234	0.000921	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ERBB3—breast cancer	0.000233	0.000915	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGFR2—breast cancer	0.000233	0.000914	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000228	0.000898	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000224	0.000881	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL2—breast cancer	0.000224	0.000881	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TERT—breast cancer	0.000223	0.000877	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TFRC—breast cancer	0.000218	0.000855	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGFR1—breast cancer	0.000217	0.000852	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HIF1A—breast cancer	0.000213	0.000839	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000209	0.000823	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LEP—breast cancer	0.000208	0.000819	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CAV1—breast cancer	0.000206	0.000812	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KDR—breast cancer	0.000204	0.000802	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ALB—breast cancer	0.000204	0.0008	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.0002	0.000785	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ESR1—breast cancer	0.000199	0.000782	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FN1—breast cancer	0.000197	0.000772	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NFKBIA—breast cancer	0.000194	0.000763	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000193	0.000758	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH1—breast cancer	0.000192	0.000756	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000191	0.000749	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.00019	0.000747	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CG—breast cancer	0.000188	0.000739	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KIT—breast cancer	0.000188	0.000739	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APC—breast cancer	0.000188	0.000739	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—ALB—breast cancer	0.000188	0.000737	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000186	0.000732	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EGF—breast cancer	0.000186	0.000731	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—RAF1—breast cancer	0.000184	0.000723	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MAPK3—breast cancer	0.00018	0.000708	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BRAF—breast cancer	0.000177	0.000695	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000176	0.000694	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IGF1—breast cancer	0.000172	0.000677	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT2—breast cancer	0.000172	0.000676	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PLG—breast cancer	0.000172	0.000676	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EGFR—breast cancer	0.000171	0.000673	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TFRC—breast cancer	0.000166	0.000652	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CD—breast cancer	0.000165	0.00065	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SERPINE1—breast cancer	0.000164	0.000643	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—KRAS—breast cancer	0.000162	0.000636	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—NCOA2—breast cancer	0.00016	0.000628	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000159	0.000624	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000159	0.000623	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOS3—breast cancer	0.000156	0.000614	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000155	0.000611	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000152	0.000599	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000152	0.000599	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CA—breast cancer	0.000149	0.000585	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MDM2—breast cancer	0.000148	0.000582	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RAF1—breast cancer	0.000148	0.00058	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000147	0.000578	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RELA—breast cancer	0.000147	0.000578	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ERBB2—breast cancer	0.000146	0.000574	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CB—breast cancer	0.000144	0.000566	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MTOR—breast cancer	0.000144	0.000566	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—ALB—breast cancer	0.000143	0.000562	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL8—breast cancer	0.000138	0.000544	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TFRC—breast cancer	0.000138	0.000544	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—HRAS—breast cancer	0.000138	0.000541	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDKN1B—breast cancer	0.000135	0.000532	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000135	0.000529	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000133	0.000524	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CASP3—breast cancer	0.000133	0.000521	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL2—breast cancer	0.000132	0.00052	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6—breast cancer	0.000132	0.000518	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	0.000131	0.000515	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCND1—breast cancer	0.000129	0.000507	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JUN—breast cancer	0.000129	0.000506	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CTNNB1—breast cancer	0.000128	0.000502	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000127	0.0005	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP9—breast cancer	0.000125	0.000492	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDKN1A—breast cancer	0.000125	0.000491	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTEN—breast cancer	0.000125	0.000489	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000123	0.000483	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAPK8—breast cancer	0.000122	0.000479	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT1—breast cancer	0.000121	0.000478	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000121	0.000476	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	0.000119	0.000469	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000116	0.000457	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SRC—breast cancer	0.000115	0.000454	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VEGFA—breast cancer	0.000112	0.000442	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000112	0.000441	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STAT3—breast cancer	0.000111	0.000438	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	0.000109	0.00043	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAPK3—breast cancer	0.000106	0.000418	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MYC—breast cancer	0.000103	0.000407	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFB1—breast cancer	0.000103	0.000406	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EGFR—breast cancer	0.000101	0.000398	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000101	0.000397	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	9.7e-05	0.000381	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KRAS—breast cancer	9.56e-05	0.000376	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ALB—breast cancer	9.53e-05	0.000375	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CA—breast cancer	8.79e-05	0.000345	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—RAF1—breast cancer	8.62e-05	0.000339	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TP53—breast cancer	8.5e-05	0.000334	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HRAS—breast cancer	8.13e-05	0.000319	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6—breast cancer	7.78e-05	0.000306	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	7.27e-05	0.000286	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT1—breast cancer	7.18e-05	0.000282	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	6.57e-05	0.000258	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	6.07e-05	0.000238	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	5.49e-05	0.000216	CbGpPWpGaD
